Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 13, 2019 (8 years ago)

Ciclopirox shampoo 1%

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Degradation/Impurities Specifications: Out of specification related substance results during stability testing.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Ciclopirox shampoo 1%,120 mL bottle, Rx only, Manufactured By Perrigo Bronx, NY 10457 Distributed by Perrigo Allegan, MI 49010, 45802-401-09

Affected NDC 45802-0401-09

Compare with the code on your package — it is the most precise check available.

Drug: Ciclopirox

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Ciclopirox
NDC 45802-0401
1 g/100mL Shampoo
Topical
Padagis Israel Pharmaceuticals Ltd Rx
Recalling firm
Perrigo New York, Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0512-2019 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ciclopirox recalls

See all
Class II · Moderate risk

Ciclopirox Shampoo

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Ongoing Impurity / degradation Sun Pharma /Taro NDC 51672-1351-08 D-0240-2026
Class III · Low risk

Ciclopirox Gel 0.77%

Defective Container: Firm received complaints of broken tube at the seal.

Ongoing Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-0455-35 D-0002-2025
Class III · Low risk

Ciclopirox Olamine Cream USP

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Terminated Failed specification G & W Laboratories, Inc. NDC 0713-0638-15 D-0250-2018
Class III · Low risk

Ciclopirox Olamine Cream USP

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Terminated Labeling / mix-up G & W Laboratories, Inc. NDC 0713-0638-15 D-0636-2017

Other recalls by Perrigo New York, Inc.

All 2019 recalls